In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.
In response to evolving regulatory expectations, the industry is moving toward integrated, risk-based, and transparent ...
The US Food and Drug Administration (FDA) has cited a medical device manufacturer and a contract drug testing laboratory for ...
Ask the Expert Video Series. Welcome to the Ask the Expert video series. This series is an extension of the PharmTech Group’s long-running print column in which industry experts ...
A California company has recalled more than 3.1 million bottles of lubricating eye drops because it had not properly tested – and thus could not prove – whether the products were sterile. These ...
Cheers and roars filled the stadium as RCB clinched their maiden IPL match against SRH on Saturday, but it wasn’t just the ...
A groundbreaking experiment revives interest in forgotten scientists Krishna Bahadur and S. Ranganayaki, exploring life's ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.
Defining combination product CQAs across drug and device enables an end-to-end control strategy that improves product quality ...
In this Pharma Matters Q&A, Amina Rahmoune of Nelson Labs evaluates and compares sterility testing in cleanrooms and isolators.
At different stages of the drug lifecycle, the minimum provision for parenteral products is a safety barrier against potential contaminants. This protection is guaranteed by selected container closure ...
More than 3 million bottles of over-the-counter eye drops are being recalled after officials raised concerns about the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results